Quick Answer Box
- What is this case? A mass tort and class action consolidated under MDL No. 2913 against Philips Respironics for defective PE-PUR foam in recalled CPAP, BiPAP, and ventilator devices that exposed millions of users to toxic particulate matter and off-gassing.
- Who qualifies? Anyone who used a recalled Philips Respironics sleep or respiratory device before the June 2021 recall, whether they suffered health injuries or only economic loss from a defective product.
- What is it worth? The economic loss settlement totals approximately $1.1 billion. Individual payouts range from roughly $100 to over $100,000 depending on claim tier, injury severity, and device usage duration. Personal injury claims for cancer and serious respiratory conditions could reach significantly higher values through separate litigation.
| Detail | Info |
|---|---|
| Court | U.S. District Court, Western District of Pennsylvania |
| Case / MDL Number | MDL No. 2913 |
| Presiding Judge | Judge Joy Flowers Conti |
| Filing Date | Consolidated October 2021 |
| Status | Economic loss settlement approved; personal injury track active |
| Settlement Fund | Approximately $1.1 billion (economic loss); personal injury TBD |
| Parent Defendant | Koninklijke Philips N.V. / Philips Respironics |
The Philips CPAP lawsuit payout per person depends on which of two distinct settlement tracks a claimant falls under, and 2026 is shaping up as the year when both tracks produce meaningful financial outcomes. An estimated 15 million devices were subject to the June 2021 FDA Class I recall. That recall covered CPAP machines, BiPAP devices, and certain mechanical ventilators manufactured by Philips Respironics, all containing PE-PUR sound abatement foam prone to degradation.
The economic loss settlement, valued at roughly $1.1 billion, received court approval and is now in the claims administration phase. Personal injury claims, covering cancer diagnoses and severe respiratory conditions, remain in active litigation within the same MDL.
For claimants watching this case in 2026, the critical questions are straightforward: how much, when, and what do I need to prove? This report covers each of those questions with specific reference to the court record in MDL 2913 and the settlement structures already in place.
What follows is a section-by-section breakdown of payout estimates, eligibility requirements, claim filing procedures, and the 2026 calendar that governs when money actually moves.
What Is the Philips CPAP Lawsuit Payout Per Person

The Philips CPAP lawsuit payout per person is the individual share a qualifying claimant receives from the settlement fund or, in the personal injury track, from a jury verdict or individual resolution. No single flat amount applies to everyone. Payouts are tiered based on the type of claim, the severity of harm, and the duration of device use.
Under the economic loss settlement, payouts cover the diminished value of the recalled device, out-of-pocket replacement costs, and related economic damages. These amounts are smaller per person because the class is enormous, spanning millions of device owners.
Under the personal injury track, individual case values are substantially higher. Claims involving diagnosed cancers or documented chronic respiratory illness carry expected settlement ranges that dwarf economic loss payouts.
*Attorney Insight:* Attorneys handling these claims point to the distinction between the two tracks as the single most important factor in estimating per-person recovery, because the legal theories, proof requirements, and available damages differ fundamentally.
| Claim Track | Typical Per-Person Range | Basis of Claim |
|---|---|---|
| Economic Loss | $100 to $1,000+ | Device replacement, diminished value |
| Personal Injury (moderate) | $10,000 to $100,000+ | Respiratory illness, non-cancer conditions |
| Personal Injury (severe) | $100,000 to $500,000+ | Cancer, death, permanent organ damage |
The wide range reflects real variation in individual circumstances. A claimant who used a DreamStation for eight years and developed lung cancer occupies a fundamentally different position than someone who owned a device for six months with no symptoms.
Philips CPAP Lawsuit Payout Per Person 2026 Projections
In 2026, the Philips CPAP lawsuit payout per person is projected to become tangible for economic loss claimants and substantially clearer for personal injury plaintiffs. The economic loss settlement's claims administration process is underway, with initial distribution checks expected to reach qualifying class members during the first half of 2026.
Personal injury payouts in 2026 depend on bellwether trial outcomes and any global personal injury settlement Philips may negotiate. As of early 2026, no comprehensive personal injury settlement has been finalized, though individual case resolutions have occurred.
The MDL court's scheduling orders for 2026 include continued case management conferences, potential bellwether trial dates, and deadlines for personal injury discovery. These procedural milestones set the pace for when money becomes available.
*Attorney Insight:* Attorneys handling these claims note that 2026 represents a pivotal year because the economic loss fund transitions from administrative processing to actual disbursement, while personal injury litigation enters the phase where trial-ready cases create pressure for global resolution.
2026 Projected Timeline:
| Quarter | Expected Activity |
|---|---|
| Q1 2026 | Economic loss claims processing continues; initial eligibility determinations |
| Q2 2026 | First economic loss distribution checks anticipated |
| Q3 2026 | Personal injury bellwether trial preparation; discovery deadlines |
| Q4 2026 | Potential personal injury settlement discussions; additional economic loss distributions |
These projections reflect the court's current scheduling posture. Delays are always possible in mass tort administration.
Philips CPAP Lawsuit Settlement Overview
The Philips CPAP lawsuit settlement refers primarily to the $1.1 billion economic loss resolution announced in September 2024 and subsequently submitted for court approval in MDL No. 2913. This settlement resolved claims from a certified class of U.S. consumers who purchased or rented recalled Philips Respironics devices.
Judge Joy Flowers Conti presides over the MDL in the Western District of Pennsylvania. The settlement covers devices sold between approximately 2009 and 2021, encompassing product lines including the DreamStation, DreamStation Go, SystemOne, and certain Trilogy ventilators.
Philips Respironics, a subsidiary of Dutch parent company Koninklijke Philips N.V., agreed to the economic loss settlement while continuing to defend against personal injury claims. The company has maintained that the PE-PUR foam poses minimal health risk based on its own testing, a position contested by plaintiffs' experts and contradicted by the FDA's Class I recall designation.
*Attorney Insight:* Attorneys handling these claims observe that the economic loss settlement's size reflects the sheer volume of affected devices rather than high per-unit value, making individual payout calculations dependent on class size and claims rate.
Key Settlement Facts:
- Total fund: Approximately $1.1 billion
- Scope: Economic loss only; personal injury excluded
- Class definition: U.S. purchasers/renters of recalled Philips Respironics devices
- Approval court: Western District of Pennsylvania, MDL 2913
- Defendant: Philips RS North America LLC / Koninklijke Philips N.V.
Litigation Watch: The two-track structure of this litigation means that economic loss claimants and personal injury plaintiffs operate on entirely different timelines, with different proof requirements and dramatically different per-person payout potential heading into 2026.
Philips CPAP Settlement Amount Per Person by Claim Tier
The Philips CPAP settlement amount per person varies across defined claim tiers established in the economic loss settlement agreement. Each tier corresponds to the type of device, the nature of economic harm, and the documentation a claimant can provide.
Claimants who can produce proof of purchase and demonstrate out-of-pocket replacement costs receive higher tier payouts. Those who submit claims based solely on device ownership without documented expenses fall into lower tiers.
The personal injury track does not use the same tier system. Instead, personal injury values are assessed individually based on diagnosis, causation evidence, and damages.
| Claim Tier | Description | Estimated Per-Person Payout |
|---|---|---|
| Tier 1 | Device ownership only, no documented expenses | $100 to $300 |
| Tier 2 | Device ownership with proof of purchase | $300 to $600 |
| Tier 3 | Documented replacement/repair costs | $600 to $1,500 |
| Tier 4 | Substantial out-of-pocket costs with receipts | $1,500 to $3,000+ |
| Personal Injury (separate track) | Diagnosed medical condition linked to device | $10,000 to $500,000+ |
*Attorney Insight:* Attorneys handling these claims emphasize that claimants who retained purchase receipts, insurance records, or correspondence with Philips regarding device replacement are positioned for higher-tier economic loss payouts.
The gap between Tier 1 and Tier 4 is significant. A claimant with a shoebox of receipts and a documented history of purchasing a replacement CPAP out-of-pocket stands to recover ten times what a claimant with no documentation receives.
How Much Will the Philips CPAP Lawsuit Pay
How much the Philips CPAP lawsuit will pay any individual claimant is a function of four variables: the settlement track, the claim tier, the total number of valid claims filed, and the deductions applied before distribution.
For the economic loss class, the $1.1 billion fund sounds large in isolation. Divided among millions of potential claimants, individual checks shrink substantially. If 5 million valid claims are filed, the average payout per person would sit around $220 before deductions. If the claims rate is lower, say 2 million claims, the average rises to approximately $550.
Claims rates in mass tort settlements typically range between 5% and 25% of eligible class members. The actual participation rate will determine whether payouts land at the low or high end of estimates.
*Attorney Insight:* Attorneys handling these claims compare the economics to the Volkswagen diesel emissions settlement, where claims rates and administrative costs significantly shaped per-person recovery. The claims rate is the single largest unknown variable.
Payout Variables at a Glance:
- Settlement fund size: $1.1 billion (economic loss)
- Estimated eligible claimants: Up to 15 million device users
- Expected claims rate: 5% to 25%
- Administrative and legal costs: Estimated 25% to 33% of fund
- Net per-person range: $100 to $3,000+ (economic loss)
- Personal injury range: $10,000 to $500,000+ (separate)
These figures reflect the structural reality of mass tort distribution. Large headline numbers produce smaller individual checks when shared across millions.
Philips CPAP Lawsuit Payout Per Person Calculator Factors
A Philips CPAP lawsuit payout per person calculator weighs several case-specific variables to estimate an individual's recovery. No official court-sanctioned calculator exists, but the factors used in claims administration are publicly known from the settlement agreement.
Key calculator factors include:
- Device type: CPAP, BiPAP, or mechanical ventilator
- Model and serial number: Confirms the device falls within the recall scope
- Duration of use: Longer use periods correlate with higher exposure and, for personal injury claims, stronger causation arguments
- Proof of purchase: Receipt, insurance claim record, or prescription documentation
- Replacement costs: Documented out-of-pocket expenses for a substitute device
- Medical expenses (personal injury track only): Treatment costs, diagnostic records, lost wages
- Injury severity (personal injury track only): Diagnosis type, permanence, and impact on daily life
*Attorney Insight:* Attorneys handling these claims advise that the most impactful calculator factor for economic loss claimants is documentation, while for personal injury claimants, the diagnosis itself carries the most weight.
| Factor | Impact on Payout | Applies To |
|---|---|---|
| Device type and model | Moderate | Both tracks |
| Duration of use | Moderate to high | Both tracks |
| Proof of purchase | High | Economic loss |
| Replacement cost documentation | High | Economic loss |
| Diagnosed medical condition | Very high | Personal injury |
| Cancer vs. non-cancer diagnosis | Very high | Personal injury |
Anyone attempting to estimate their own payout should start by gathering every document related to the device and any medical treatment that followed its use.
Litigation Watch: Per-person payouts in the economic loss track are driven less by the severity of harm and more by administrative factors like claims rates and documentation quality, while personal injury values hinge almost entirely on the medical evidence connecting foam exposure to a specific diagnosis.
Philips CPAP Lawsuit Payout Date and Distribution Timeline
The Philips CPAP lawsuit payout date for economic loss claimants is projected to fall within mid-2026, based on the claims administration timeline established after settlement approval. No exact check-mailing date has been announced by the claims administrator as of early 2026.
The distribution timeline follows a standard sequence in mass tort settlements: settlement approval, claims filing period, eligibility review, objection resolution, and then disbursement. Each phase carries its own duration.
Distribution Timeline:
| Phase | Estimated Period |
|---|---|
| Settlement approval | Completed (2024/2025) |
| Claims filing window | Open through mid-2026 |
| Eligibility verification | Rolling through 2026 |
| Objection and appeal period | Q1 to Q2 2026 |
| Initial distribution | Mid to late 2026 |
| Supplemental distributions | Late 2026 through 2027 |
Personal injury payouts do not follow this timeline. Those payments depend on individual case resolutions, whether through trial verdicts, negotiated settlements, or a future global personal injury settlement agreement.
*Attorney Insight:* Attorneys handling these claims stress that initial distributions often cover only a portion of the total payout, with supplemental checks issued later as the claims administrator resolves remaining disputes and recalculates pro rata shares.
Claimants should expect that the first check may not represent their full entitlement. Supplemental payments are standard in settlements of this scale.
Philips CPAP Lawsuit Update 2026: Where the Case Stands
The Philips CPAP lawsuit in 2026 is at a crossroads. The economic loss settlement has moved past approval and into the operational phase. Personal injury litigation remains active, with bellwether case selection and trial preparation continuing under Judge Conti's supervision.
Several developments define the 2026 posture of MDL 2913:
- Economic loss claims administration is processing submitted claims and verifying eligibility
- Personal injury discovery continues, with expert reports and medical record reviews ongoing
- Bellwether trials for personal injury claims are being scheduled, with potential trial dates in late 2026 or early 2027
- Philips' financial disclosures indicate the company has reserved additional funds for potential personal injury resolution
- FDA oversight of the recall remediation program continues, with the agency monitoring device replacement and repair efforts
*Attorney Insight:* Attorneys handling these claims view the bellwether trial schedule as the most consequential development in 2026, because trial outcomes in the first few personal injury cases will set the valuation framework for thousands of pending claims.
2026 Case Status Summary:
| Component | Status |
|---|---|
| Economic loss settlement | Approved; claims processing underway |
| Personal injury litigation | Active; bellwether preparation |
| Bellwether trial dates | Anticipated late 2026 to early 2027 |
| FDA recall status | Ongoing; Class I designation unchanged |
| Philips financial reserves | Additional provisions disclosed |
The dual-track nature of this MDL means that 2026 activity is simultaneous: one track is distributing money while the other is preparing for trial.
Philips CPAP Economic Loss Settlement Details
The Philips CPAP economic loss settlement is a $1.1 billion class-wide resolution that covers U.S. consumers who purchased or rented recalled Philips Respironics sleep and respiratory devices. The settlement was reached in September 2024 and received preliminary approval from the court shortly after.
This settlement compensates class members for the economic harm of owning a defective product. It does not cover personal injuries, medical expenses related to health conditions, or pain and suffering. Those claims fall under the separate personal injury track.
What the economic loss settlement covers:
- Diminished value of the recalled device
- Out-of-pocket costs for device replacement
- Costs of alternative sleep therapy during the recall period
- Insurance copays and deductibles related to obtaining a new device
- Inconvenience and disruption damages (limited)
What it does not cover:
- Cancer diagnoses
- Respiratory illness treatment costs
- Lost wages due to health conditions
- Pain and suffering
- Wrongful death
*Attorney Insight:* Attorneys handling these claims note that the economic loss settlement's exclusion of health-related damages is not a concession by plaintiffs but a strategic separation that allows personal injury claims to be valued independently, without the diluting effect of millions of economic-only claims.
| Settlement Element | Detail |
|---|---|
| Total fund | $1.1 billion |
| Class size | Millions of U.S. device owners/renters |
| Covered devices | DreamStation, SystemOne, DreamStation Go, Trilogy ventilators, others |
| Coverage period | Devices purchased/rented approximately 2009 to 2021 |
| Excluded claims | Personal injury, medical monitoring (handled separately) |
Litigation Watch: The economic loss settlement's $1.1 billion fund is being administered now, but its per-person impact is shaped by the claims rate and documentation requirements, while the personal injury track's value remains unresolved and potentially far larger on a per-claimant basis.
Philips CPAP Personal Injury Settlement Status
The Philips CPAP personal injury settlement has not been finalized as of early 2026. Unlike the economic loss track, personal injury claims remain in active litigation within MDL 2913. No global personal injury settlement agreement has been announced.
Personal injury plaintiffs allege that inhaling degraded PE-PUR foam particles and chemical off-gassing caused serious health conditions. The most common alleged injuries include:
- Lung cancer
- Kidney cancer
- Liver cancer
- Chronic respiratory conditions (asthma exacerbation, COPD worsening, interstitial lung disease)
- Headaches, dizziness, and upper airway irritation
- Death (wrongful death claims filed by surviving family members)
The personal injury track involves individualized proof. Each plaintiff must establish that their specific medical condition was caused or worsened by exposure to the defective foam. This requires medical records, expert testimony, and, in many cases, pathology reports.
*Attorney Insight:* Attorneys handling these claims report that cancer claims carry the highest individual case values, but also face the highest causation burden, requiring plaintiffs' medical experts to connect the specific type of cancer to the chemical compounds released by PE-PUR foam degradation.
| Injury Category | Estimated Individual Settlement Range | Causation Burden |
|---|---|---|
| Lung cancer | $250,000 to $500,000+ | High |
| Kidney/liver cancer | $200,000 to $450,000+ | High |
| Chronic respiratory disease | $50,000 to $150,000 | Moderate |
| Upper airway irritation | $10,000 to $50,000 | Lower |
| Wrongful death | $500,000 to $1,000,000+ | High |
These ranges are based on comparable mass tort personal injury settlements and are subject to change based on bellwether trial outcomes.
Philips CPAP Lawsuit Eligibility Requirements
Eligibility for the Philips CPAP lawsuit depends on which settlement track a claimant seeks to join. The economic loss track and the personal injury track have different qualifying criteria.
Economic loss eligibility requires:
- U.S. residency or device purchase/rental within the United States
- Ownership or rental of a Philips Respironics device covered by the June 2021 recall
- The device must be one of the models identified in the recall notice (DreamStation, SystemOne, DreamStation Go, Trilogy 100/200, and others)
- The claim must be filed within the designated claims window
Personal injury eligibility requires all of the above, plus:
- A diagnosed medical condition alleged to be caused by exposure to degraded PE-PUR foam
- Medical records supporting the diagnosis and its temporal relationship to device use
- Evidence of device usage duration and pattern (nightly use, hours per night)
*Attorney Insight:* Attorneys handling these claims advise that economic loss eligibility is relatively straightforward, requiring only proof of device ownership, while personal injury eligibility demands a substantially more developed evidentiary record.
| Eligibility Factor | Economic Loss | Personal Injury |
|---|---|---|
| U.S. device ownership | Required | Required |
| Recalled model | Required | Required |
| Proof of purchase | Strengthens claim | Required |
| Medical diagnosis | Not required | Required |
| Expert medical opinion | Not required | Typically required |
| Usage duration evidence | Helpful | Important |
Claimants unsure whether their device is covered can check the serial number against Philips Respironics' official recall list, which identifies affected models and production date ranges.
How to File a Philips CPAP Lawsuit Claim
Filing a Philips CPAP lawsuit claim involves either submitting a claim form through the economic loss settlement's claims administrator or retaining an attorney to file a personal injury claim in MDL 2913.
For economic loss claims:
- Obtain the official claim form from the court-appointed claims administrator
- Gather supporting documentation (proof of purchase, device serial number, replacement receipts)
- Complete the form with accurate information about the recalled device
- Submit the form before the claims deadline
- Await eligibility determination and payout notification
For personal injury claims:
- Consult with an attorney experienced in mass tort or product liability litigation
- Provide medical records documenting the diagnosed condition
- Share device usage history and any communications with Philips regarding the recall
- The attorney files a complaint or short-form complaint in MDL 2913
- The claim enters the personal injury litigation track for individual or global resolution
*Attorney Insight:* Attorneys handling these claims stress that economic loss claims can be filed without legal representation, but personal injury claims virtually always require counsel due to the complexity of causation evidence and the litigation demands of the MDL process.
| Filing Method | Best For | Attorney Needed? |
|---|---|---|
| Claims administrator form | Economic loss claims | Optional but helpful |
| MDL complaint filing | Personal injury claims | Strongly recommended |
| Individual state court filing | Some personal injury claims | Required |
The claims administrator processes economic loss forms on a rolling basis. Personal injury filings follow the MDL court's procedural schedule.
Litigation Watch: Filing procedures differ sharply between the two tracks. Economic loss claimants can self-file through the claims administrator, but personal injury plaintiffs need counsel to present the medical and scientific evidence required to connect their diagnosis to PE-PUR foam exposure.
Philips CPAP Lawsuit Deadline 2026: Key Dates
The Philips CPAP lawsuit deadline for economic loss claims is tied to the claims filing window established in the settlement agreement. As of early 2026, the claims window remains open, but a definitive closing date is expected to be set by mid-2026.
Personal injury claims face statute of limitations considerations that vary by state. Most states apply a two-to-three-year statute of limitations for personal injury claims, typically running from the date of diagnosis or the date the plaintiff knew or should have known that the device caused their condition.
Key 2026 Dates:
| Deadline | Approximate Date | Applies To |
|---|---|---|
| Economic loss claims filing window closes | Mid-2026 (exact date TBD by court) | All economic loss claimants |
| Personal injury statute of limitations | Varies by state (2 to 3 years from discovery) | Individual personal injury plaintiffs |
| Bellwether trial scheduling | Late 2026 to early 2027 | Personal injury track |
| Supplemental distribution deadline | Late 2026 to 2027 | Economic loss claimants |
*Attorney Insight:* Attorneys handling these claims warn that waiting too long to file a personal injury claim risks running into a statute of limitations bar, especially for claimants diagnosed in 2023 or 2024 who have not yet filed suit.
Critical consideration: Some states apply a "discovery rule" that starts the limitations clock when the plaintiff learns of the connection between their device and their injury. Others use a strict accrual date tied to the diagnosis itself. This state-by-state variation makes timely consultation with an attorney essential for personal injury claimants.
Philips CPAP Foam Degradation Lawsuit Background
The Philips CPAP foam degradation lawsuit stems from a defect in the PE-PUR (polyester-based polyurethane) sound abatement foam used in Philips Respironics sleep and respiratory devices. This foam was designed to reduce noise and vibration. Instead, it broke down under normal operating conditions, releasing particulate matter and potentially toxic gases directly into the device's air pathway.
On June 14, 2021, Philips Respironics issued a voluntary recall affecting an estimated 15 million devices worldwide. The FDA subsequently classified the recall as Class I, its most serious designation, indicating a reasonable probability that use of the product could cause serious adverse health consequences or death.
The recalled devices included:
- DreamStation (CPAP and BiPAP)
- DreamStation Go (travel CPAP)
- SystemOne (CPAP and BiPAP)
- Trilogy 100 and Trilogy 200 (ventilators)
- Garbin Plus, LifeVent, A-Series BiPAP (various respiratory devices)
*Attorney Insight:* Attorneys handling these claims point out that the Class I recall designation by the FDA is one of the strongest pieces of evidence plaintiffs can cite, because it reflects the agency's own determination that the defect posed a serious health risk.
The foam degradation was accelerated by several factors: heat, humidity, and the use of ozone-based cleaning products. Many CPAP users had been advised by third-party companies to clean their devices with ozone generators, which Philips later acknowledged could worsen foam breakdown.
| Defect Element | Detail |
|---|---|
| Defective component | PE-PUR sound abatement foam |
| Failure mode | Foam degradation, particulate release, chemical off-gassing |
| Accelerating factors | Heat, humidity, ozone-based cleaners |
| Recall date | June 14, 2021 |
| FDA classification | Class I (most serious) |
| Devices affected | Approximately 15 million worldwide |
Philips CPAP Class Action Settlement Structure
The Philips CPAP class action settlement is structured as a hybrid resolution. The economic loss component operates as a traditional class action settlement with a certified class and a common fund. The personal injury component operates as a mass tort with individualized claims.
Economic loss class action structure:
- A single certified class of U.S. consumers
- Common fund of approximately $1.1 billion
- Claims processed by a court-appointed administrator
- Pro rata distribution based on claim tier and documentation
- Common benefit fund deductions for plaintiffs' attorneys who contributed to the litigation
Personal injury mass tort structure:
- Individual claims filed by each plaintiff
- No certified class for personal injury claims
- Each case evaluated on its own facts (diagnosis, causation, damages)
- Bellwether trials used to establish valuation benchmarks
- Potential for a future global personal injury settlement, but none agreed upon yet
*Attorney Insight:* Attorneys handling these claims compare this dual structure to the Bayer/Roundup litigation, where economic and health claims were resolved through different mechanisms, with personal injury cases commanding substantially higher individual values.
| Structural Feature | Economic Loss Track | Personal Injury Track |
|---|---|---|
| Class certification | Yes | No |
| Common fund | $1.1 billion | Not yet established |
| Claims process | Administrator form | Individual litigation |
| Proof required | Device ownership | Medical causation |
| Attorney involvement | Optional | Essential |
| Payout timing | Mid-2026 projected | TBD (bellwether dependent) |
This structure allows economic loss claimants to receive compensation relatively quickly while preserving the right of personal injury plaintiffs to pursue full damages for their individual health conditions.
Litigation Watch: The hybrid structure of this settlement means two different legal systems are processing claims simultaneously. Economic loss claimants wait for the claims administrator, while personal injury plaintiffs wait for bellwether trials to set the valuation framework that will drive either individual settlements or a global resolution.
Philips CPAP Recall Settlement Payout Process
The Philips CPAP recall settlement payout process follows a defined administrative sequence from claim submission to check delivery. Understanding this process helps claimants set realistic expectations about timing and amounts.
Step-by-step payout process for economic loss claims:
- Claim submission: Claimant completes and submits the official claim form with supporting documentation
- Initial review: Claims administrator verifies that the device model and serial number fall within the recall scope
- Documentation review: Administrator assesses proof of purchase, replacement costs, and any other economic loss evidence
- Tier assignment: Claim is assigned to the appropriate payout tier based on documentation strength
- Eligibility determination: Administrator issues a written eligibility decision
- Objection period: Claimant may dispute the tier assignment or eligibility finding
- Distribution calculation: Once all claims are processed, the administrator calculates pro rata shares based on the total fund, claim count, and tier distribution
- Payment issuance: Checks or electronic payments are sent to qualifying claimants
- Supplemental distribution: If funds remain after initial distribution, supplemental payments are issued
*Attorney Insight:* Attorneys handling these claims note that the pro rata calculation in Step 7 is where the "per person" number becomes real, because it depends on how many total claims are filed and how they distribute across tiers.
| Process Step | Estimated Duration |
|---|---|
| Claim submission to initial review | 30 to 60 days |
| Documentation review | 60 to 90 days |
| Tier assignment and eligibility | 30 to 60 days |
| Objection resolution | 30 to 90 days |
| Distribution calculation | 60 to 120 days |
| Payment issuance | 30 days after calculation |
The entire process from claim submission to first payment typically spans 6 to 12 months in settlements of this size.
Philips CPAP MDL Settlement Update and Court Activity
MDL No. 2913 remains one of the largest active product liability MDLs in the federal court system. The case, formally styled In Re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation, continues under the supervision of Judge Joy Flowers Conti in the Western District of Pennsylvania.
Recent and ongoing court activity includes:
- Economic loss settlement implementation: The claims administrator is actively processing submitted forms and issuing eligibility determinations
- Personal injury case management orders: Judge Conti has issued scheduling orders governing discovery, expert disclosure, and bellwether trial preparation
- Plaintiffs' Steering Committee activity: The PSC continues to coordinate litigation strategy across thousands of personal injury claims
- Philips' motions practice: The defendant has filed various motions challenging causation theories and seeking to exclude certain expert testimony (Daubert challenges)
- State court coordination: Some personal injury cases filed in state courts are being coordinated with the federal MDL proceedings
*Attorney Insight:* Attorneys handling these claims report that the Daubert challenges filed by Philips regarding plaintiffs' medical causation experts will be among the most consequential rulings in 2026, because they determine whether the scientific evidence linking foam exposure to cancer reaches a jury.
| MDL 2913 Activity | Status as of 2026 |
|---|---|
| Economic loss settlement | Claims processing underway |
| Personal injury litigation | Active discovery and bellwether prep |
| Bellwether case selection | Ongoing |
| Daubert motions (expert challenges) | Pending ruling |
| Global PI settlement talks | Not yet announced |
| Court conferences | Regularly scheduled |
The outcome of expert testimony challenges could reshape the entire personal injury litigation. If plaintiffs' experts survive Daubert scrutiny, Philips faces substantial trial exposure. If key experts are excluded, the causation case weakens, potentially reducing settlement leverage.
Litigation Watch: MDL 2913 enters 2026 with two active fronts: an administrative operation distributing economic loss funds and a courtroom battle over whether the scientific evidence connecting PE-PUR foam to cancer and respiratory disease will reach a jury. The Daubert rulings expected this year could define the ceiling on personal injury case values.
Frequently Asked Questions
How much will each person receive from the Philips CPAP lawsuit settlement?
Economic loss claimants can expect $100 to $3,000+ depending on their claim tier and documentation.
Personal injury claimants with cancer or serious respiratory conditions may receive $50,000 to $500,000+ through individual settlements or verdicts.
The exact amount depends on the total number of claims filed and the strength of each individual claim.
When will Philips CPAP lawsuit payouts be distributed in 2026?
Initial economic loss distribution checks are projected for mid to late 2026.
The claims administrator must first complete eligibility review and pro rata calculations before issuing payments.
Personal injury payouts have no set date and depend on bellwether trial outcomes or individual case resolutions.
Who qualifies for the Philips CPAP lawsuit settlement?
Any U.S. resident who purchased or rented a Philips Respironics device covered by the June 2021 recall qualifies for the economic loss track.
Personal injury claimants must also have a diagnosed medical condition linked to PE-PUR foam exposure.
Eligible devices include the DreamStation, SystemOne, DreamStation Go, Trilogy ventilators, and other recalled models.
Is the Philips CPAP personal injury settlement separate from the economic loss settlement?
Yes, the two settlement tracks are entirely separate.
The $1.1 billion economic loss settlement covers device-related financial losses only.
Personal injury claims for cancer, respiratory disease, and wrongful death are litigated individually within MDL 2913 and have not been resolved through a global settlement.
What is the deadline to file a Philips CPAP lawsuit claim in 2026?
The economic loss claims filing window is expected to close by mid-2026, though the exact date is set by the court.
Personal injury claims are governed by state-specific statutes of limitations, typically two to three years from the date of diagnosis or discovery of the connection to the device.
Claimants should consult an attorney promptly to avoid missing applicable deadlines.
How do attorney fees affect my Philips CPAP settlement payout?
For economic loss claims filed without an attorney, no individual attorney fee is deducted, though the settlement fund is reduced by common benefit fund contributions to the Plaintiffs' Steering Committee.
For personal injury claims, most attorneys work on a contingency fee basis, typically 33% to 40% of the recovery.
Lien resolution for Medicare, Medicaid, or private insurance reimbursement may further reduce the net payout.
What Comes Next
The Philips CPAP litigation is producing real financial outcomes in 2026. Economic loss checks are moving toward distribution. Personal injury cases are approaching the trial phase that will determine their ultimate value.
For anyone who used a recalled Philips Respironics device, the immediate step is straightforward: confirm that your device is on the recall list, gather your documentation, and file your economic loss claim before the window closes. If you have a diagnosed health condition potentially linked to the device, speaking with a product liability attorney who handles Philips CPAP personal injury cases is the necessary next step before any statute of limitations deadline passes.
